Testing should not be done in all patients treated with clopidogrel who are undergoing percutaneous coronary intervention

Circ Cardiovasc Interv. 2011 Oct 1;4(5):514-21; discussion 521. doi: 10.1161/CIRCINTERVENTIONS.111.962142.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aryl Hydrocarbon Hydroxylases / metabolism*
  • Biomarkers, Pharmacological / metabolism*
  • Clopidogrel
  • Cytochrome P-450 CYP2C19
  • Genetic Testing*
  • Humans
  • Platelet Aggregation Inhibitors*
  • Ticlopidine / analogs & derivatives*

Substances

  • Biomarkers, Pharmacological
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Aryl Hydrocarbon Hydroxylases
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • Ticlopidine